Evidence map›Paper›PMID 40303516›Full record

ArticleCureus2025

Intraosseous Basivertebral Nerve Ablation in the Treatment of Vertebrogenic Back Pain Secondary to Advanced Osteopenia: A Case Report.

Daniel J Lopez, Rafael A Peralta, Leon Anijar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel J LopezPain Medicine, University of Florida, Gainesville, USA.
Rafael A PeraltaEmergency Medicine, HCA Westside Regional Medical Center, Plantation, USA.
Leon AnijarPain Medicine, Spine and Wellness Centers of America, Aventura, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low back pain in advanced osteopenia and osteoporosis continues to challenge the pain provider in offering effective analgesia for this growing population. Basivertebral nerve ablation is proven to benefit vertebrogenic back pain. A relative contraindication to basivertebral nerve ablation is metabolic bone disease. An 81-year-old male with a medical history of advanced osteopenia, with a T-score of -2.2, presented to an outpatient pain clinic with chronic low back pain. MRI of the spine demonstrated Type 1 and Type 2 Modic changes of the L3, L4, and L5 vertebral endplates, without evidence of fracture. The patient underwent an intraosseous basivertebral nerve ablation of the L3, L4, and L5 vertebrae, and follow-up appointments up to six months demonstrated a reduction in the patient's Numeric Pain Rating Scale by 6 and an improvement in quality of life. We successfully performed intraosseous basivertebral nerve ablations in a patient with advanced osteopenia, for the treatment of vertebrogenic back pain.

Indexed as

back painbasivertebral nerve ablationosteopeniaosteoporosispain management

Identifiers

PMID40303516
PMCPMC12039860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.